{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:29:10Z","timestamp":1774992550337,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,27]]},"DOI":"10.7759\/cureus.41017","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T08:37:16Z","timestamp":1687855036000},"source":"Crossref","is-referenced-by-count":3,"title":["Safety of Antithyroid Drugs in Avoiding Hyperglycemia or Hypoglycemia in Patients With Graves\u2019 Disease and Type 2 Diabetes Mellitus: A Literature Review"],"prefix":"10.7759","author":[{"given":"Yu-Shan","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-019-00700-4","article-title":"Thyroid dysfunction and type 2 diabetes mellitus: screening strategies and implications for management","volume":"10","author":"Kalra S","year":"2019","unstructured":"Kalra S, Aggarwal S, Khandelwal D. Thyroid dysfunction and type 2 diabetes mellitus: screening strategies and implications for management. Diabetes Ther. 2019, 10:2035-44. 10.1007\/s13300-019-00700-4","journal-title":"Diabetes Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2019.11.01","article-title":"Hyperthyroidism","volume":"9","author":"Doubleday AR","year":"2020","unstructured":"Doubleday AR, Sippel RS. Hyperthyroidism. Gland Surg. 2020, 9:124-35. 10.21037\/gs.2019.11.01","journal-title":"Gland Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo S","year":"2016","unstructured":"De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016, 388:906-18. 10.1016\/S0140-6736(16)00278-6","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-18584","article-title":"Thyroid hormone excess and glucose intolerance","volume":"109","author":"Dimitriadis GD","year":"2001","unstructured":"Dimitriadis GD, Raptis SA. Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes. 2001, 109:S225-39. 10.1055\/s-2001-18584","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/439463","article-title":"Thyroid disorders and diabetes mellitus","volume":"2011","author":"Hage M","year":"2011","unstructured":"Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res. 2011, 2011:439463. 10.4061\/2011\/439463","journal-title":"J Thyroid Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1271691","article-title":"Prevalence of thyroid dysfunction in patients with type 2 diabetes","volume":"119","author":"D\u00edez JJ","year":"2011","unstructured":"D\u00edez JJ, S\u00e1nchez P, Iglesias P. Prevalence of thyroid dysfunction in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2011, 119:201-7. 10.1055\/s-0031-1271691","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1820-0","article-title":"Glycemic variation in uncontrolled Graves' disease patients with normal glucose metabolism: Assessment by continuous glucose monitoring","volume":"64","author":"Gao G","year":"2019","unstructured":"Gao G, Li FF, Hu Y, et al.. Glycemic variation in uncontrolled Graves' disease patients with normal glucose metabolism: Assessment by continuous glucose monitoring. Endocrine. 2019, 64:265-70. 10.1007\/s12020-018-1820-0","journal-title":"Endocrine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-018-1018-0","article-title":"Hypoglycemia among patients with type 2 diabetes: epidemiology, risk factors, and prevention strategies","volume":"18","author":"Silbert R","year":"2018","unstructured":"Silbert R, Salcido-Montenegro A, Rodriguez-Gutierrez R, Katabi A, McCoy RG. Hypoglycemia among patients with type 2 diabetes: epidemiology, risk factors, and prevention strategies. Curr Diab Rep. 2018, 18:53. 10.1007\/s11892-018-1018-0","journal-title":"Curr Diab Rep"},{"key":"ref9","unstructured":"National Diabetes Statistics Report, 2020. estimates of diabetes and its burden in the United States. (2020). Accessed: March 10, 2022: https:\/\/www.cdc.gov\/diabetes\/pdfs\/data\/statistics\/national-diabetes-statistics-report.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2217\/DMT.13.73","article-title":"Understanding hypoglycemia in hospitalized patients","volume":"4","author":"Hulkower RD","year":"2014","unstructured":"Hulkower RD, Pollack RM, Zonszein J. Understanding hypoglycemia in hospitalized patients. Diabetes Manag (Lond). 2014, 4:165-76. 10.2217\/DMT.13.73","journal-title":"Diabetes Manag (Lond)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej13-0410","article-title":"Glucose variability before and after treatment of a patient with Graves' disease complicated by diabetes mellitus: assessment by continuous glucose monitoring","volume":"61","author":"Torimoto K","year":"2014","unstructured":"Torimoto K, Okada Y, Arao T, et al.. Glucose variability before and after treatment of a patient with Graves' disease complicated by diabetes mellitus: assessment by continuous glucose monitoring. Endocr J. 2014, 61:321-8. 10.1507\/endocrj.ej13-0410","journal-title":"Endocr J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9721-0","article-title":"Hypoglycemia due to insulin binding antibodies in a patient with insulin-treated type 2 diabetes and Graves' disease","volume":"43","author":"Wang X","year":"2013","unstructured":"Wang X, Xu XL, Zhao XL, et al.. Hypoglycemia due to insulin binding antibodies in a patient with insulin-treated type 2 diabetes and Graves' disease. Endocrine. 2013, 43:236-7. 10.1007\/s12020-012-9721-0","journal-title":"Endocrine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2006.21.4.765","article-title":"A case of hyperglycemic hyperosmolar state associated with Graves' hyperthyroidism: a case report","volume":"21","author":"Moon SW","year":"2006","unstructured":"Moon SW, Hahm JR, Lee GW, et al.. A case of hyperglycemic hyperosmolar state associated with Graves' hyperthyroidism: a case report. J Korean Med Sci. 2006, 21:765-7. 10.3346\/jkms.2006.21.4.765","journal-title":"J Korean Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228896","article-title":"Case study of thyrotoxic cardiomyopathy","volume":"12","author":"Alam ST","year":"2019","unstructured":"Alam ST, Zaman J. Case study of thyrotoxic cardiomyopathy. BMJ Case Rep. 2019, 12:10.1136\/bcr-2018-228896","journal-title":"BMJ Case Rep"},{"key":"ref15","article-title":"Hyperthyroidism induces glucose intolerance by lowering both insulin secretion and peripheral insulin sensitivity","volume":"89 Suppl 5","author":"Roubsanthisuk W","year":"2006","unstructured":"Roubsanthisuk W, Watanakejorn P, Tunlakit M, Sriussadaporn S. Hyperthyroidism induces glucose intolerance by lowering both insulin secretion and peripheral insulin sensitivity. J Med Assoc Thai. 2006, 89 Suppl 5:S133-40.","journal-title":"J Med Assoc Thai"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1042\/cs1040007","article-title":"Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism","volume":"104","author":"Rochon C","year":"2003","unstructured":"Rochon C, Tauveron I, Dejax C, et al.. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci (Lond). 2003, 104:7-15.","journal-title":"Clin Sci (Lond)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0246","article-title":"Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism","volume":"163","author":"Maratou E","year":"2010","unstructured":"Maratou E, Hadjidakis DJ, Peppa M, et al.. Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. Eur J Endocrinol. 2010, 163:625-30. 10.1530\/EJE-10-0246","journal-title":"Eur J Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/168565","article-title":"Severe hypoglycemia accompanied with thyroid crisis","volume":"2012","author":"Nakatani Y","year":"2012","unstructured":"Nakatani Y, Monden T, Sato M, Domeki N, Matsumura M, Banba N, Nakamoto T. Severe hypoglycemia accompanied with thyroid crisis. Case Rep Endocrinol. 2012, 2012:168565. 10.1155\/2012\/168565","journal-title":"Case Rep Endocrinol"},{"key":"ref19","article-title":"A case of profound hypoglycemia in the setting of starvation and beta-adrenergic blockade in a patient with hyperthyroidism","volume":"4","author":"Lee CW","year":"2018","unstructured":"Lee CW, Mathew H, Steenkamp D. A case of profound hypoglycemia in the setting of starvation and beta-adrenergic blockade in a patient with hyperthyroidism. AACE Clin Case Rep. 2018, 4:353-7.","journal-title":"AACE Clin Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/br.2017.932","article-title":"Glucose metabolism before and after radioiodine therapy of a patient with Graves' disease: Assessment by continuous glucose monitoring","volume":"7","author":"Hu Y","year":"2017","unstructured":"Hu Y, Gao G, Yan RN, Li FF, Su XF, Ma JH. Glucose metabolism before and after radioiodine therapy of a patient with Graves' disease: Assessment by continuous glucose monitoring. Biomed Rep. 2017, 7:183-7. 10.3892\/br.2017.932","journal-title":"Biomed Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj1954.36.125","article-title":"Hyperglucagonemia of insulin autoimmune syndrome induced by methimazole in a patient with Graves' disease","volume":"36","author":"Yoshikawa H","year":"1989","unstructured":"Yoshikawa H, Kawai K, Inoue S, et al.. Hyperglucagonemia of insulin autoimmune syndrome induced by methimazole in a patient with Graves' disease. Endocrinol Jpn. 1989, 36:125-34. 10.1507\/endocrj1954.36.125","journal-title":"Endocrinol Jpn"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.94","article-title":"Yangxin Tongmai Formula ameliorates impaired glucose tolerance in children with Graves' disease through upregulation of the insulin receptor levels","volume":"39","author":"Luo YH","year":"2018","unstructured":"Luo YH, Zhu M, Wang DG, Yang YS, Tan T, Zhu H, He JF. Yangxin Tongmai Formula ameliorates impaired glucose tolerance in children with Graves' disease through upregulation of the insulin receptor levels. Acta Pharmacol Sin. 2018, 39:923-9. 10.1038\/aps.2017.94","journal-title":"Acta Pharmacol Sin"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-018-0352-4","article-title":"Diabetes mellitus and thyroid diseases","volume":"9","author":"Nishi M","year":"2018","unstructured":"Nishi M. Diabetes mellitus and thyroid diseases. Diabetol Int. 2018, 9:108-12. 10.1007\/s13340-018-0352-4","journal-title":"Diabetol Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/endo.135.2.8033812","article-title":"Regulation of GLUT2 glucose transporter expression in liver by thyroid hormone: evidence for hormonal regulation of the hepatic glucose transport system","volume":"135","author":"Weinstein SP","year":"1994","unstructured":"Weinstein SP, O'Boyle E, Fisher M, Haber RS. Regulation of GLUT2 glucose transporter expression in liver by thyroid hormone: evidence for hormonal regulation of the hepatic glucose transport system. Endocrinology. 1994, 135:649-54. 10.1210\/endo.135.2.8033812","journal-title":"Endocrinology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5090852","article-title":"Circulating betatrophin is increased in patients with overt and subclinical hypothyroidism","volume":"2016","author":"Han C","year":"2016","unstructured":"Han C, Xia X, Liu A, et al.. Circulating betatrophin is increased in patients with overt and subclinical hypothyroidism. Biomed Res Int. 2016, 2016:5090852. 10.1155\/2016\/5090852","journal-title":"Biomed Res Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-019-00095-8","article-title":"Decreased circulating levels of ANGPTL8 in Graves' disease patients","volume":"18","author":"Li H","year":"2019","unstructured":"Li H, Xu M, Zhao L, et al.. Decreased circulating levels of ANGPTL8 in Graves' disease patients. Hormones (Athens). 2019, 18:189-95. 10.1007\/s42000-019-00095-8","journal-title":"Hormones (Athens)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0689","article-title":"Alpha-lipoic acid and insulin autoimmune syndrome","volume":"30","author":"Ishida Y","year":"2007","unstructured":"Ishida Y, Ohara T, Okuno Y, et al.. Alpha-lipoic acid and insulin autoimmune syndrome. Diabetes Care. 2007, 30:2240-1. 10.2337\/dc07-0689","journal-title":"Diabetes Care"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013486","article-title":"Insulin autoimmune syndrome: three case reports","volume":"97","author":"Chen F","year":"2018","unstructured":"Chen F, Yang J, Liu Y, et al.. Insulin autoimmune syndrome: three case reports. Medicine (Baltimore). 2018, 97:e13486. 10.1097\/MD.0000000000013486","journal-title":"Medicine (Baltimore)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13170","article-title":"A case of pyoderma gangrenosum induced by insulin","volume":"16","author":"Noronha M","year":"2019","unstructured":"Noronha M, Arora S, Pai K, Sathish Pai B, Jindal A. A case of pyoderma gangrenosum induced by insulin. Int Wound J. 2019, 16:1239-42. 10.1111\/iwj.13170","journal-title":"Int Wound J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0308-7","article-title":"Drug-induced pyoderma gangrenosum: a review","volume":"19","author":"Wang JY","year":"2018","unstructured":"Wang JY, French LE, Shear NH, Amiri A, Alavi A. Drug-induced pyoderma gangrenosum: a review. Am J Clin Dermatol. 2018, 19:67-77. 10.1007\/s40257-017-0308-7","journal-title":"Am J Clin Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.58.685.680","article-title":"Thyroid disease in diabetics","volume":"58","author":"Sugrue DD","year":"1982","unstructured":"Sugrue DD, McEvoy M, Drury MI. Thyroid disease in diabetics. Postgrad Med J. 1982, 58:680-4. 10.1136\/pgmj.58.685.680","journal-title":"Postgrad Med J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028253","article-title":"Non-diabetic ketoacidosis secondary to primary hyperthyroidism: a case report","volume":"101","author":"Al-Mashdali AF","year":"2022","unstructured":"Al-Mashdali AF, Gul M, Umer W, Omar A, Jones A. Non-diabetic ketoacidosis secondary to primary hyperthyroidism: a case report. Medicine (Baltimore). 2022, 101:e28253. 10.1097\/MD.0000000000028253","journal-title":"Medicine (Baltimore)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4103\/cjhr.cjhr_14_17","article-title":"Unusual antithyroid drug-induced hypoglycemia","author":"Gutch M BA","year":"2017","unstructured":"Gutch M BA, Kumar S, Pahan RK, Singh RS. Unusual antithyroid drug-induced hypoglycemia. CHRISMED J Health Res. 2017, 10.4103\/cjhr.cjhr_14_17","journal-title":"CHRISMED J Health Res"},{"key":"ref34","article-title":"Insulin autoimmune syndrome in a patient with methimazole and carbimazole-treated Graves' disease: a case report","volume":"54","author":"Lu CC","year":"1994","unstructured":"Lu CC, Lee JK, Lam HC, Yang CY, Han TM. Insulin autoimmune syndrome in a patient with methimazole and carbimazole-treated Graves' disease: a case report. Zhonghua Yi Xue Za Zhi (Taipei). 1994, 54:353-8.","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/2042018816658396","article-title":"Methimazole-induced insulin autoimmune syndrome","volume":"7","author":"Jain N","year":"2016","unstructured":"Jain N, Savani M, Agarwal M, Kadaria D. Methimazole-induced insulin autoimmune syndrome. Ther Adv Endocrinol Metab. 2016, 7:178-81. 10.1177\/2042018816658396","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/s1726-4901(09)70140-6","article-title":"Severe hypoglycemic coma due to insulin autoimmune syndrome","volume":"68","author":"Ma WY","year":"2005","unstructured":"Ma WY, Won JG, Tang KT, Lin HD. Severe hypoglycemic coma due to insulin autoimmune syndrome. J Chin Med Assoc. 2005, 68:82-6. 10.1016\/s1726-4901(09)70140-6","journal-title":"J Chin Med Assoc"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2012.00884.x","article-title":"Severe hypoglycemia secondary to\u00a0methimazole-induced insulin autoimmune syndrome in a 16 year old African-American male","volume":"13","author":"Gomez Cruz MJ","year":"2012","unstructured":"Gomez Cruz MJ, Jabbar M, Saini N, et al.. Severe hypoglycemia secondary to\u00a0methimazole-induced insulin autoimmune syndrome in a 16 year old African-American male. Pediatr Diabetes. 2012, 13:652-5. 10.1111\/j.1399-5448.2012.00884.x","journal-title":"Pediatr Diabetes"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2021.6577","article-title":"Scientific opinion on the relationship between intake of alpha-lipoic acid (thioctic acid) and the risk of insulin autoimmune syndrome","volume":"19","author":"Turck D","year":"2021","unstructured":"Turck D, Castenmiller J, de Henauw S, et al.. Scientific opinion on the relationship between intake of alpha-lipoic acid (thioctic acid) and the risk of insulin autoimmune syndrome. EFSA J. 2021, 19:e06577. 10.2903\/j.efsa.2021.6577","journal-title":"EFSA J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.3.873","article-title":"Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome","volume":"180","author":"Matsushita S","year":"1994","unstructured":"Matsushita S, Takahashi K, Motoki M, Komoriya K, Ikagawa S, Nishimura Y. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med. 1994, 180:873-83. 10.1084\/jem.180.3.873","journal-title":"J Exp Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.77.1.8325948","article-title":"Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62\/Cw4\/DR4 carrying DRB1*0406","volume":"77","author":"Uchigata Y","year":"1993","unstructured":"Uchigata Y, Kuwata S, Tsushima T, et al.. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62\/Cw4\/DR4 carrying DRB1*0406. J Clin Endocrinol Metab. 1993, 77:249-54. 10.1210\/jcem.77.1.8325948","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2013.28.1.55","article-title":"Two cases of methimazole-induced insulin autoimmune syndrome in graves' disease","volume":"28","author":"Roh E","year":"2013","unstructured":"Roh E, Kim YA, Ku EJ, et al.. Two cases of methimazole-induced insulin autoimmune syndrome in graves' disease. Endocrinol Metab (Seoul). 2013, 28:55-60. 10.3803\/EnM.2013.28.1.55","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref42","article-title":"Insulin auto-antibodies produced by methimazole treatment in the patients with Graves' disease","volume":"50","author":"Takei M","year":"1980","unstructured":"Takei M. Insulin auto-antibodies produced by methimazole treatment in the patients with Graves' disease. J Tokyo Women's Medical College. 1980, 50:54.","journal-title":"J Tokyo Women's Medical College"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029337","article-title":"Case report: hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in young Taiwanese woman with Graves' disease","volume":"101","author":"Wu HY","year":"2022","unstructured":"Wu HY, Chen IH, Lee MY. Case report: hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in young Taiwanese woman with Graves' disease. Medicine (Baltimore). 2022, 101:e29337. 10.1097\/MD.0000000000029337","journal-title":"Medicine (Baltimore)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.1893","article-title":"Insulin autoimmune syndrome possibly caused by alpha lipoic acid","volume":"46","author":"Takeuchi Y","year":"2007","unstructured":"Takeuchi Y, Miyamoto T, Kakizawa T, Shigematsu S, Hashizume K. Insulin autoimmune syndrome possibly caused by alpha lipoic acid. Intern Med. 2007, 46:237-9. 10.2169\/internalmedicine.46.1893","journal-title":"Intern Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2014.1964","article-title":"Hypoglycemic coma due to insulin autoimmune syndrome induced by methimazole: a rare case report","volume":"8","author":"Zhang Y","year":"2014","unstructured":"Zhang Y, Zhao T. Hypoglycemic coma due to insulin autoimmune syndrome induced by methimazole: a rare case report. Exp Ther Med. 2014, 8:1581-4. 10.3892\/etm.2014.1964","journal-title":"Exp Ther Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90080-m","article-title":"Strong association of insulin autoimmune syndrome with HLA-DR4","volume":"339","author":"Uchigata Y","year":"1992","unstructured":"Uchigata Y, Kuwata S, Tokunaga K, et al.. Strong association of insulin autoimmune syndrome with HLA-DR4. Lancet. 1992, 339:393-4. 10.1016\/0140-6736(92)90080-m","journal-title":"Lancet"},{"key":"ref47","article-title":"Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors","volume":"151","author":"Ito Y","year":"1993","unstructured":"Ito Y, Nieda M, Uchigata Y, et al.. Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol. 1993, 151:5770-6.","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-5-199603010-00005","article-title":"Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease","volume":"124","author":"Tamai H","year":"1996","unstructured":"Tamai H, Sudo T, Kimura A, et al.. Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease. Ann Intern Med. 1996, 124:490-4. 10.7326\/0003-4819-124-5-199603010-00005","journal-title":"Ann Intern Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9221","article-title":"Methimazole-induced insulin autoimmune syndrome in Graves' disease with hypokalemia: a case report and literature review","volume":"20","author":"Han R","year":"2020","unstructured":"Han R, Jiang X. Methimazole-induced insulin autoimmune syndrome in Graves' disease with hypokalemia: a case report and literature review. Exp Ther Med. 2020, 20:93. 10.3892\/etm.2020.9221","journal-title":"Exp Ther Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3767","article-title":"Insulin-induced autoimmune syndrome: a case report","volume":"12","author":"Chu JP","year":"2016","unstructured":"Chu JP, Zheng XW, Lu J, Zhong JY, Li JL, Xu M, Lin F. Insulin-induced autoimmune syndrome: a case report. Exp Ther Med. 2016, 12:3359-62. 10.3892\/etm.2016.3767","journal-title":"Exp Ther Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/161192-safety-of-antithyroid-drugs-in-avoiding-hyperglycemia-or-hypoglycemia-in-patients-with-graves-disease-and-type-2-diabetes-mellitus-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:30Z","timestamp":1707509130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/161192-safety-of-antithyroid-drugs-in-avoiding-hyperglycemia-or-hypoglycemia-in-patients-with-graves-disease-and-type-2-diabetes-mellitus-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.41017","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,27]]}}}